iopamidol has been researched along with Lupus Erythematosus, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, A; Tsuji, T; Yamauchi, R | 1 |
| Barrie, R; Dawson, P; Ghosh, S; Muhlemann, M; Pusey, CD; Savill, JS | 1 |
2 other study(ies) available for iopamidol and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Fixed drug eruption caused by iopamidol, a contrast medium.
Topics: Adult; Apoptosis; Contrast Media; Drug Eruptions; fas Receptor; Female; Humans; Immunohistochemistry; Iopamidol; Keratinocytes; Lupus Erythematosus, Systemic; Patch Tests; Skin | 1997 |
Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus.
Topics: Female; Humans; Iopamidol; Lupus Erythematosus, Systemic; Middle Aged; Stevens-Johnson Syndrome; Urography | 1988 |